Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Actinium Pharmaceuticals
ATNM
$26.3M
| $1.21M | ﹤0.01% |
152,678
+52,872
| +53% | +$415K |
|
3502
POSCO
PKX
$16.1B
| $1.2M | ﹤0.01% |
15,685
-1,891
| -11% | -$150K |
|
|
CTG
3503
DELISTED
Computer Task Group, Inc.
CTG
| $1.2M | ﹤0.01% |
124,438
+14,075
| +13% | +$141K |
|
3504
IZEA Worldwide
IZEA
$60.6M
| $1.2M | ﹤0.01% |
117,878
+13,923
| +13% | +$183K |
|
3505
Genprex
GNPX
$3.02M
| $1.2M | ﹤0.01% |
8
-4
| -33% | -$656K |
|
|
BMTX
3506
DELISTED
BM Technologies, Inc.
BMTX
| $1.2M | ﹤0.01% |
96,573
+8,986
| +10% | +$104K |
|
|
ASPU
3507
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.19M | ﹤0.01% |
182,912
-171,314
| -48% | -$977K |
|
|
MMAC
3508
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $1.19M | ﹤0.01% |
43,879
-29,144
| -40% | -$629K |
|
3509
Arq
ARQ
$84.6M
| $1.19M | ﹤0.01% |
160,675
-109,261
| -40% | -$673K |
|
|
GDP
3510
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $1.18M | ﹤0.01% |
79,143
-55,876
| -41% | -$627K |
|
3511
ING
ING
$99.8B
| $1.18M | ﹤0.01% |
89,180
+3,942
| +5% | +$51.7K |
|
|
TFFP
3512
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $1.18M | ﹤0.01% |
4,892
+616
| +14% | +$169K |
|
|
AFI
3513
DELISTED
Armstrong Flooring, Inc.
AFI
| $1.18M | ﹤0.01% |
189,973
+11,245
| +6% | +$64.5K |
|
|
LJPC
3514
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.17M | ﹤0.01% |
274,361
-142,226
| -34% | -$609K |
|
3515
Afya
AFYA
$1.31B
| $1.17M | ﹤0.01% |
45,434
+388
| +0.9% | +$9.13K |
|
|
FTCH
3516
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $1.17M | ﹤0.01% |
23,231
+2,234
| +11% | +$106K |
|
3517
Union Bankshares
UNB
$106M
| $1.16M | ﹤0.01% |
32,066
+319
| +1% | +$10.7K |
|
3518
First Capital
FCAP
$212M
| $1.16M | ﹤0.01% |
26,681
-21,970
| -45% | -$996K |
|
3519
Voyager Therapeutics
VYGR
$183M
| $1.15M | ﹤0.01% |
278,126
-186,692
| -40% | -$846K |
|
|
JAX
3520
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $1.15M | ﹤0.01% |
98,636
+3,655
| +4% | +$40.3K |
|
3521
Exicure
XCUR
$10.2M
| $1.14M | ﹤0.01% |
5,089
-2,663
| -34% | -$698K |
|
3522
Townsquare Media
TSQ
$106M
| $1.14M | ﹤0.01% |
89,485
+28,811
| +47% | +$343K |
|
3523
Mitsubishi UFJ Financial
MUFG
$253B
| $1.14M | ﹤0.01% |
210,036
+9,520
| +5% | +$52.9K |
|
3524
Karat Packaging
KRT
$803M
| $1.14M | ﹤0.01% |
+55,782
| New | +$1.06M |
|
|
LEVL
3525
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $1.14M | ﹤0.01% |
41,647
-33,529
| -45% | -$902K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.